Joe D. Lewis
Corporate Officer/Principal bei The European Molecular Biology Laboratory
Profil
Joe D.
Lewis was the founder of Elara Pharmaceuticals GmbH, which was founded in 2006, where he held the title of Chief Executive Officer from 2006 to 2009.
Currently, he is the Head-Chemical Biology at The European Molecular Biology Laboratory.
In the past, he worked as a Group Leader at Anadys Pharmaceuticals, Inc. and as a Group Leader-Wellcome Trust Centre at The University of Edinburgh from 1996 to 2001.
Dr. Lewis holds a doctorate degree from the University of Vienna.
Aktive Positionen von Joe D. Lewis
| Unternehmen | Position | Beginn |
|---|---|---|
| The European Molecular Biology Laboratory | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Joe D. Lewis
| Unternehmen | Position | Ende |
|---|---|---|
| The University of Edinburgh | Corporate Officer/Principal | - |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Corporate Officer/Principal | - |
Elara Pharmaceuticals GmbH
 Elara Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Elara Pharmaceuticals GmbH focuses on the development of novel treatments for malignant diseases. It has developed three distinct and proprietary dual mechanism chemotypes that potently inhibit the HIF signaling pathway and induce apoptosis. The firm has identified compounds with excellent in vitro activity against a diverse set of tumor cell lines and superior pharmacokinetic and toxicity profiles in vivo. The company was founded by Frank Gannon, Joe D. Lewis and George Reid on July 27, 2006 and is headquartered in Heidelberg, Germany. | Vorstandsvorsitzender | - |
Ausbildung von Joe D. Lewis
| University of Vienna | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Elara Pharmaceuticals GmbH
Elara Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Elara Pharmaceuticals GmbH focuses on the development of novel treatments for malignant diseases. It has developed three distinct and proprietary dual mechanism chemotypes that potently inhibit the HIF signaling pathway and induce apoptosis. The firm has identified compounds with excellent in vitro activity against a diverse set of tumor cell lines and superior pharmacokinetic and toxicity profiles in vivo. The company was founded by Frank Gannon, Joe D. Lewis and George Reid on July 27, 2006 and is headquartered in Heidelberg, Germany. | Health Technology |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Health Technology |
